By Tom Crosby, RESI Conference Manager, LSN
Don’t miss an excellent chance to hear directly from pharma executives looking to fill pipeline gaps via strategic partnerships & alliances; LSN is bringing together representatives from some of the most active big pharma companies involved in early stage life sciences.
Moderated by Bill Kohlbrenner of AbbVie, the audience will hear from:
- Florian Puehler, Alliance Manager at Bayer HealthCare
- Richard Brudnick, Vice President of Business Development and M&A at Biogen Idec
- Donnie McGrath, Vice President of Business Development at Bristol-Myers Squibb
- Melinda Richter, Head of Janssen Labs, Johnson & Johnson
- Michael Draper, Director of Scouting and Partnering at Sanofi
Panelists will discuss in-depth the key motivators behind big pharma’s shift towards an early stage strategy as a way to fill the gaps in their pipelines. What indication areas are the most sought after? How does an early stage entrepreneur interface with business development executives from pharmaceutical companies? LSN’s Big Pharma RESI Panelists will shed light on these questions and more.
Hear from big pharma executives as they explain how they engage with early stage startups, and how they like to be contacted. The speakers will help the audience understand their timeline for contact, and give advice on how to create a dialogue that leads to a relationship and an eventual alliance. If you need to understand the timeframe and limitations of how big pharma corporate works, this expert session is crucial for you to attend.
Next Phase Newsletter 
Leave a comment